The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Isoray
Research Funding - AstraZeneca
Xevinapant with radiation and concurrent carboplatin and paclitaxel in patients ineligible for cisplatin with locoregionally advanced squamous cell carcinoma of the head and neck (EXtRaCT study).
 
Nabiel Ali Mir
No Relationships to Disclose
 
Aditya Juloori
No Relationships to Disclose
 
Paul Swiecicki
Honoraria - CDR-Life; Elevar Therapeutics; Elevar Therapeutics; Geovax Labs; Prelude Therapeutics; Remix Therapeutics; Seagen
Research Funding - Ascentage Pharma Group (Inst)
 
Rohan Reddy Katipally
No Relationships to Disclose
 
Nishant Agrawal
Leadership - OrisDX
Stock and Other Ownership Interests - Haystack Oncology; OrisDX; Privo Technologies
Patents, Royalties, Other Intellectual Property - Patent pending for salivary diagnostics to diagnose oral cancer.
 
Elizabeth A. Blair
No Relationships to Disclose
 
Daniel J. Haraf
Patents, Royalties, Other Intellectual Property - Author for UpToDate
 
Alexander T. Pearson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics
Research Funding - Abbvie (Inst); EMD Serono (Inst); Kura Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals; McKesson
Honoraria - Ascendis Pharma (I)
Consulting or Advisory Role - Ascendis Pharma (I)
Research Funding - Abbvie; Alliance Pharma; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis
 
Ari Joseph Rosenberg
Stock and Other Ownership Interests - Galectin Therapeutics; Privo Technologies
Consulting or Advisory Role - Astellas Pharma; Eisai; EMD Serono; Nanobiotix; Novartis; Regeneron; Vaccitech
Speakers' Bureau - Coherus Biosciences
Research Funding - Abbvie (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene (Inst); EMD Serono (Inst); Hookipa Biotech (Inst); Purple Biotech (Inst)